A UK prospective cohort study suggested that habitual use of glucosamine supplement to relieve osteoarthritis pain might also be related to lower risks of cardiovascular diseases (CVD) events. The study enrolled 466 039 participants from 2006 to 2010. During a median follow-up of 7 years, there were 10 204 incident CVD events, 3060 CVD deaths, 5745 coronary heart disease events, and 3263 stroke events. After adjustment for age, sex, body mass index, race, lifestyle factors, dietary intakes, drug use, and other supplement use, glucosamine use was associated with a significantly lower risk of total CVD events (hazard ratio 0.85), CVD death (0.78), coronary heart disease (0.82), and stroke (0.91). The findings are in line with several previous studies and suggest that glucosamine might have a preventive role in CVD through anti-inflammatory and mimicking a low carbohydrate diet properties. Source: https://www.bmj.com/
A Spanish secondary prevention study suggested that Mediterranean diet might reduce neutrophil levels and slow…
Top 10 key takeaway points of the report of the American College of Cardiology Solution…
A UK device-based prospective study suggested that irregular sleep was associated with higher risk of…
A Chinese parallel design, randomized clinical trial showed that the incidence of major cardiovascular events…
A study comparing UK adults conceived just before or after sugar rationing ended found that…
A Chinese nationwide case-crossover study revealed that lower temperatures were associated with higher risks of…
This website uses cookies.